Phio Pharmaceuticals GAAP EPS of -$1.54 beats by $2.60

Phio Pharmaceuticals press release ( NASDAQ: PHIO ): Q3 GAAP EPS of -$1.54 beats by $2.60 .

At September 30, 2024, the company had cash of $5.4 million as compared with $8.5 million at December 31, 2023.



More on Phio Pharmaceuticals Seeking Alpha’s Quant Rating on Phio Pharmaceuticals Historical earnings data for Phio Pharmaceuticals Financial information for Phio Pharmaceuticals.